- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 18, 2026 | 405.56M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 404.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 401.65M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$512.91K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$31.34K |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $898.48K |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $205.88K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$3.45M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$2.21M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $40.54M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $39.61M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $41.77M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $40.29M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $38.08M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $37.99M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $38.08M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $37.99M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $152.75K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $41.38K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.31M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$61.38K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$152.75K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$41.38K |
| Capex | Q1 2026 · Jun 30, 2025 | $50K |
| Capex | Q1 2026 · May 2, 2025 | $50K |
| Capex | Q1 2026 · May 1, 2025 | $50K |